GRI Bio, Inc. Common Stock Share Price

NYSE: GRIHealthcare

$1.75

-0.1 (5.41%)

BUY SELL

Share Price
Performance Overview
Fundamentals
Return Calculator
Company Info
Popular Stocks
FAQ

Live GRI Bio, Inc. Common Stock Share Price Chart

O H L

GRI Bio, Inc. Common Stock Performance Overview

Days Range

▼

$1.78Low

$1.85High

Markets Today

Previous Close	$1.84
Open	$1.85
Volume	57,605
Day's Range	$1.78 - $1.85
52W Range	$1.36 - $64.12
Market Cap	$3.96 M

Historical Performance

1M Returns	+7.60
3M Returns	-2.13
6M Returns	-30.57
1Y Returns	-96.60
5Y Returns	NA
10Y Returns	-100.00

GRI Bio, Inc. Common Stock Fundamentals

Market Cap	$3.96 M
Dividend yield	0.00
PE Ratio	0.00
PEG Ratio	N/A
Revenue	$0.00
ROE TTM	-2.38
EPS TTM	$-51.65
Quarterly Earnings Growth YOY	N/A
PB Ratio	0.38
EBITDA	$-11.97 M
Profit Margin	N/A

Market Cap	$3.96 M
Dividend yield	0.00
PE Ratio	0.00
PEG Ratio	N/A
Revenue	$0.00
ROE TTM	-2.38

EPS TTM	$-51.65
Quarterly Earnings Growth YOY	N/A
PB Ratio	0.38
EBITDA	$-11.97 M
Profit Margin	N/A

GRI Bio, Inc. Common Stock Profit & Loss

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue +	$0	$0	$0	$0	$0	$0
Gross Profit +	$0	$0	$0	$0	$0	$0
Operating Income	-$3.05 M	-$2.90 M	-$3.37 M	-$2.66 M	-$2.00 M	-$1.65 M
EBITDA	-$3.05 M	-$2.90 M	-$3.36 M	-$2.66 M	-$2.00 M	-$1.65 M
Interest Expense	$5.00 K	$5.00 K	$0	$0	$5.00 K	$5.00 K
Depreciation	$1.00 K	$1.00 K	$1.00 K	$1.00 K	$1.00 K	$0
Income Before Tax	-$3.05 M	-$2.89 M	-$3.36 M	-$2.66 M	-$2.00 M	-$1.64 M
Income Tax Expense	$0	$0	$0	$0	$0	$0
Net Income +	-$3.05 M	-$2.89 M	-$3.36 M	-$2.66 M	-$2.00 M	-$1.64 M
Net Profit Margin	-	-	-	-	-	-

GRI Bio, Inc. Common Stock Financials Balance Sheet In USD

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Share Capital	$0	$0	$0	$0	$0	$0
Reserve & Surplus	-$42.79 M	-$45.68 M	-$49.04 M	-$51.70 M	-$53.69 M	-$55.34 M
Non-Current Liabilities	$58.00 K	$44.00 K	$30.00 K	$15.00 K	$0	$0
Current Liabilities	$2.78 M	$2.31 M	$2.76 M	$2.64 M	$794.00 K	$1.10 M
Total Liabilities	$2.84 M	$2.35 M	$2.79 M	$2.66 M	$794.00 K	$1.10 M
Fixed Assets	$3.00 K	$2.00 K	$1.00 K	$3.00 K	$2.00 K	$2.00 K
Current Assets	$3.93 M	$5.58 M	$4.70 M	$8.59 M	$11.28 M	$11.33 M
Total Assets	$4.04 M	$5.67 M	$4.78 M	$8.67 M	$11.34 M	$11.38 M

GRI Bio, Inc. Common Stock Cash Flow

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-$3.05 M	-$2.89 M	-$3.36 M	-$2.66 M	-$2.00 M	-$1.64 M
Operating Cash Flow	-$1.74 M	-$3.17 M	-$2.31 M	-$2.97 M	-$3.69 M	-$1.45 M
Investing Cash Flow	$0	$0	$0	-$3.00 K	$0	$0
Financing Cash Flow	-$11.00 K	$5.01 M	$1.25 M	$7.15 M	$6.50 M	$1.34 M
Change in Cash	-$1.75 M	$1.84 M	-$1.07 M	$4.17 M	$2.82 M	-$101.00 K

GRI Bio, Inc. Common Stock Return Calculator

The GRI Bio, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT

$10,000

Select Duration

5Yrs

1 Yr5 Yrs

If you had invested $10,000 5 years ago, what would its value be today?$10,000

Invested Amount$10,000

Est. Returns$0

Invest in USA Stock Today

About GRI Bio, Inc. Common Stock

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

FAQs

What is the share price of GRI Bio, Inc. Common Stock today?

GRI Bio, Inc. Common Stock (GRI) share price as of September 18, 2026 is $1.75. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of GRI Bio, Inc. Common Stock?

Yes, Indian Investors can invest in the GRI Bio, Inc. Common Stock (GRI) Share by opening an international trading account with Angel One.

How can I purchase GRI Bio, Inc. Common Stock shares in India?

Purchasing GRI Bio, Inc. Common Stock (GRI) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying GRI Bio, Inc. Common Stock (GRI) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of GRI Bio, Inc. Common Stock?

Yes, you can purchase fractional shares of GRI Bio, Inc. Common Stock (GRI) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of GRI Bio, Inc. Common Stock?

The market capitalization of GRI Bio, Inc. Common Stock on September 18, 2026, is $3.96 M.

In which sector GRI Bio, Inc. Common Stock belongs?

GRI Bio, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.

What documents are required to invest in GRI Bio, Inc. Common Stock stocks?

In order to invest in GRI Bio, Inc. Common Stock (GRI) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.